Dendritic cell immunotherapy in uterine cancer

Novel dendritic cell-based vaccination in late stage melanoma

Tumor cell lysates as immunogenic sources for cancer vaccine design

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Dendritic cells in cancer immunotherapy clinical trials: are we making progress?

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go

Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial

Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer

Dendritic cell-based immunotherapy in ovarian cancer

Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma